GEISTWERT Rechtsanwälte Lawyers Avvocati

https-www.unifiedpatentcourt.org-en-node-182907-93d9a03ba9af

SANOFI-AVENTIS DEUTSCHLAND GMBH, SANOFI-AVENTIS GROUPE S.A., SANOFI WINTHROP INDUSTRIE S.A., and Regeneron Pharmaceuticals Inc. v. AMGEN, INC

Date
2026-03-25
Division
Luxembourg (LU)
Type of action
Withdrawal (RoP265)
Language
EN

Metadata

Case IDhttps-www.unifiedpatentcourt.org-en-node-182907-93d9a03ba9af
Case number
Registry number
Order reference
Keywords
Headnotes

Documents and full text

Extractor: pypdf | Pages: 4

1 DECISION of the Court of Appeal of the Unified Patent Court issued on 25 March 2026 concerning an application for withdrawal (R. 265 RoP) regarding an application for rehearing (R. 245 RoP) and an application for reimbusement of Court fees (R. 370.9 RoP) APPLICANTS (RESPONDENTS BEFORE THE COURT OF APPEAL AND CLAIMANTS BEFORE THE COURT OF FIRST INSTANCE) 1. SANOFI-AVENTIS DEUTSCHLAND GMBH, Brüningstrasse 50, 65926, Frankfurt am Main, Germany 2. SANOFI-AVENTIS GROUPE S.A., 82 Avenue Raspail, 94250 Gentilly, France 3. SANOFI WINTHROP INDUSTRIE S.A., 82 Avenue Raspail, 94250 Gentilly, France hereinafter: (”Sanofi”) represented by Daniel Wise, attorney-at-law, Carpmaels & Ransford, London, The United Kingdom and other representatives from that law firm and Regeneron Pharmaceuticals Inc., 777  ...